U.S. biotechs raises more capital

The capital drought for biotech companies in recent years has probably not escaped anyone. Now, however, we are getting hopeful signals from the U.S. The Financial Times reports that U.S. biotech companies managed to raise a total of USD 6.2 billion in January, which is the highest number in a single month since February 2021, when biotech was at its peak.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/02/u-s-biotechs-raises-more-capital/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se